Medicaid Prescription Formulary Restrictions and Arthritis Treatment Costs
Author(s) -
Tricia J. Johnson,
Stephanie Stahl-Moncada
Publication year - 2008
Publication title -
american journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.284
H-Index - 264
eISSN - 1541-0048
pISSN - 0090-0036
DOI - 10.2105/ajph.2007.118133
Subject(s) - formulary , medicine , medicaid , medical prescription , pharmacy , ambulatory , rheumatoid arthritis , prescription drug , family medicine , ambulatory care , emergency medicine , managed care , health care , pharmacology , economics , economic growth
We used the Arizona Medicaid program as a model to examine the consequences of the relative restrictiveness of nonsteroidal anti-inflammatory drug (NSAID)-preferred drug lists on health care use and costs for Medicaid enrollees with arthritis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom